http://www.eurekalert.org/pub_releases/2010-01/w-cca010510.php
Public release date: 5-Jan-2010
Contact: Dawn Peters
Wiley-Blackwell
Caffeine consumption associated with less severe liver fibrosis
Study finds caffeine in sources other than coffee does not have similar effect
Researchers from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) determined that patients with chronic hepatitis C virus (HCV) who consumed more than 308 mg of caffeine daily had milder liver fibrosis. The daily amount of caffeine intake found to be beneficial is equivalent to 2.25 cups of regular coffee. Other sources of caffeine beyond coffee did not have the same therapeutic effect.
----- (skipping)
Researchers further evaluated caffeine and coffee separately to determine the individual effect of each on fibrosis. Results showed that consumption of caffeinated soda, green or black tea was not associated with reduced liver fibrosis. However, a significant protective effect could have been missed due to small numbers, as 71% of total caffeine consumed came from coffee. Caffeinated coffee had the most pronounced effect on reduced liver fibrosis. The authors suggest that further research is needed to determine if the protective benefits of coffee/caffeine intake plateau at amounts beyond the daily consumption threshold.
====================================
So it might not be the caffeine, it might be something in coffee that is reduced when it is de-caffeinated.
No comments:
Post a Comment